Market Overview

ThermoGenesis Announces Approval of AXP by India Ministry of Health

ThermoGenesis Corp. (NASDAQ: KOOL) said today that India's Ministry of Health has approved the AutoXpress® System, enabling the Company to initiate commercial sales of the product in India. The AXP is used for the processing of stem cells from cord blood.

Posted-In: News FDA

 

Most Popular

Related Articles (KOOL)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free